Can you believe EZALLOR SPRINKLE received compensation for the extended wait time during the regulatory approval process?
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10413543 | SUN PHARM | Stable multiparticulate pharmaceutical composition of rosuvastatin |
Feb, 2036
(11 years from now) | |
Ezallor Sprinkle is owned by Sun Pharm.
Ezallor Sprinkle contains Rosuvastatin Calcium.
Ezallor Sprinkle has a total of 1 drug patent out of which 0 drug patents have expired.
Ezallor Sprinkle was authorised for market use on 18 December, 2018.
Ezallor Sprinkle is available in capsule;oral dosage forms.
The generics of Ezallor Sprinkle are possible to be released after 12 February, 2036.
Drugs and Companies using ROSUVASTATIN CALCIUM ingredient
Market Authorisation Date: 18 December, 2018
Treatment: NA
Dosage: CAPSULE;ORAL
More Information on Dosage
EZALLOR SPRINKLE family patents
